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INTRODUCTION 
The Health Law and Policy Programs at UNH School of Law, Institute for Health Policy and 
Practice, and the NH Citizens Health Initiative have contracted with several of the New 
Hampshire Building Capacity for Transformation Delivery System Reform Incentive Payment 
(DSRIP) Integrated Delivery Networks (IDN) to provide technical assistance to the IDNs as they 
develop confidentiality tools related to substance use disorder services projects.     
A UNH Team assisted the IDNs by providing an educational summary of federal and state 
confidentiality requirements, focusing on 42 CFR Part 2, and hosting IDN interdisciplinary 
teams in three Substance Use Disorder (SUD) Treatment Confidentiality Boot Camp sessions 
providing technical assistance to assist each IDN partner with their SUD confidentiality project 
goals. The “boot camp” consisted of several guided meetings with assigned homework to 
follow, leading to the ultimate development of processes, plans, and draft forms and policies 
to implement Part 2 confidentiality. The process incorporated learning from the Citizens 
Health Initiative’s existing New Hampshire Behavioral Health Integration Learning 
Collaborative.  
 
The Project was implemented during half-day working sessions between May 15 – July 30, 
based upon the availability of IDN interdisciplinary teams and as arranged in collaboration with 
the IDNs. The IDNs committed to including project leaders with knowledge about and 
authority to investigate issues regarding projects, patient flow, and privacy. The project teams 
were multi-disciplinary. IDN participants were encouraged to review issues, forms, and ideas 
with their individual legal counsel at any point. The technical assistance provided as part of 
this project is not and does not take the place of legal advice.  
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DESCRIPTION OF WORK, TIMELINE, AND TEAMS 
Timeline 
 
Establish IDN Teams 
Each participating IDN identified an IDN team liaison who assisted with communications, 
coordination, and attendance of staff within their IDN and across their own regional IDN 
providers. Team liaisons helped coordinate follow up between meetings.  
Participating IDNs committed to full participation at all in-person meetings beginning at the 
inception of the project. IDN team liaisons helped the IDN partner select each IDN’s multi-
disciplinary Boot Camp team members with responsibility for administration and delivery of 
IDN SUD services. This multi-disciplinary Boot Camp team assisted participating IDNs with the 
development and implementation of SUD specific confidentiality protections, specifically the 
development and adoption of compliant practices consistent with newly amended 42 CFR Part 
2. The multi-disciplinary Boot Camp team included at least some of the following: 
• Behavioral health providers, those who do and do not provide SUD services 
• Risk managers 
• Health information management/privacy managers 
• Practice managers 
• Primary care providers 
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Each IDN’s multi-disciplinary team was responsible for addressing:  
• Project summaries 
• Identification of participating entities 
• Patient flow 
• Electronic Health Record capacities  
• System culture 
• Desired goals of integrating care 
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Worksheet Template: Identify Your Team: 
 
Name Role Organization Contact Info 
 IDN Boot Camp Lead   
 Health System/Provider   
 BH Provider Rep(s)   
 SUD Provider Rep(s)   




 Practice Manager(s)   
 Primary Care   
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WHAT IS PART 2? 
42 CFR Part 2 are the federal substance use disorder (SUD) confidentiality regulations issued 
by the U.S. Department of Health and Human Services Substance Abuse and Mental Health 
Services Administration (SAMHSA). These regulations protect the confidentiality of SUD 
treatment records. 
The Part 2 rules were recently amended with the first substantial update to the Confidentiality 
of Alcohol and Drug Abuse Patient Records (Part 2) regulations since 1987. The changes to Part 
2 are designed to: 
• Encourage care integration and information exchange, 
• Address healthcare technology changes, 
• Address prohibition against re-disclosures and accounting for disclosures, 
• Address research uses of data, and 
• Address security of records. 
The proposed amendments were published on February 9, 2016 with a comment period that 
ended on April 9, 2016. The final rule was published on January 18, 2017 to be effective 
February 17, 2017, but the Trump administration delayed effectiveness until March 2017. 
Purpose of 42 CFR Part 2 (Part 2) 
The purpose of Part 2 is to protect patients from any unintended bias associated with 
substance use disorders. The heightened confidentiality protections of Part 2 protect SUD 
patients who seek treatment from the potentially harmful consequences of having their 
patient records available to others who do not need access to them.1 The goal is to encourage 
people to seek SUD treatment, rather than not, because they can do so without fear of their 
information being shared.2  
To accomplish this goal, Part 2 strictly prohibits the disclosure and use of SUD patient records 
except with the patient’s specific written consent or under certain limited exceptions.3 The 
lawful recipient of SUD records is also prohibited from re-disclosing the information except 
with written patient consent or when another Part 2 exception applies. 
                                                             
1 Confidentiality of Substance Use Disorder Patient Records, 42 C.F.R. § 2.2(b)(2) (2017). 
2 42 C.F.R. § 2.2(b)(2) (2017). 
3 Id. 
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Why is Part 2 an issue now? 
The Part 2 rules protect SUD patient information, but in order for providers to provide good quality 
care, it is important to understand the circumstances that allow for disclosure. 
The heightened confidentiality of substance use disorder records in Part 2 is in conflict with the 
theory that mind and body should be treated as one with no stigma associated with behavioral 
health. Despite this conflict, the recent changes to Part 2 were designed to accommodate 
integrated delivery models and to “better align them with advances in the U.S. health care 
delivery system” while retaining the necessary privacy protections.4 “SAMHSA wants to ensure 
that patients with substance use disorders have the ability to participate in, and benefit from 
health system delivery improvements, including from new integrated health care models while 









Providers, payers, and data users have heightened awareness of Part 2 protections in 2017 due 
to a number of recent developments. First, the new updated Part 2 rules went into effect in 
March of 2017. Second, recent changes to health insurance coverage as a result of the 
Affordable Care Act means many more individuals now have coverage for “essential health 
benefits” including SUDs. Therefore, patients with health insurance, including those in the 
New Hampshire Health Protection Program and traditional Medicaid (including managed 
care), have better access to SUD treatments. More treating providers have access to 
confidential SUD treatment records and need to be aware of Part 2 protections. Finally, the 
opioid crisis has focused New Hampshire on the need for treatment and services, and the need 
for more integrated care for patients, again, heightening our need to be careful of SUD patient 
privacy rights. 
                                                             
4 Confidentiality of Substance Use Disorder Patient Records, 82 Fed. Reg. 6052, 6053 (Jan. 18, 2017) (to be 
codified at 42 C.F.R. Pt. 2). 
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OVERVIEW OF APPLICABLE PRIVACY AND  
CONFIDENTIALITY LAWS 
State and federal laws and regulations work together to provide protection of patient health 
information and govern the confidentiality of patient information.  
The chart below provides a brief overview of New Hampshire and federal laws and regulations 
that govern confidentiality in New Hampshire. All providers should already be familiar with the 
Health Insurance Portability and Accountability Act of 1996 (HIPAA).6 Other privacy 
regulations may not be as familiar, like the Confidentiality and Drug Abuse Patient Records, 42 
CFR Part 2 (Part 2), that have undergone recent changes. This Boot Camp and accompanying 
Work Book is meant to help the IDNs understand the amended Part 2 and implement 
appropriate policies and practices now that the regulation is finalized. 
Jurisdiction Statue/Regulation Scope 
HIPAA Privacy 
Rules 
Protects individually identifiable health information maintained 
by providers, payers, and their contractors from disclosure. 
Heightened protections for psychotherapy notes. 
42 CFR Part 2 
Protects the confidentiality of substance abuse patient records 
from disclosure without express patient consent. 
RSA 332-I:1 
Medical information in medical records in the possession of any 
health care provider shall be deemed to be the property of the 
patient. 
RSA 318-B:12-a 
Protects reports and records of treatment of minors for drug 
dependency as confidential. 
RSA 330-A:32 
Protects communications between mental health practitioners 
and patients as privileged. 
RSA 330-C:26 
Protects information held by a licensed alcohol or other drug 
use professional performing substance use counseling services 
unless permitted by 42 CFR Part 2. 
RSA 135-C:19-a 
Requires and/or permits the disclosure of certain information by 
treating providers and community mental health centers to 
designated receiving facilities (DRFs) regarding patients who 
are seriously mentally ill.7 
 
                                                             
6 Health Insurance Portability and Accountability Act, 45 C.F.R. §§ 160, 162, and 164 (2009). 
7 Practitioners treating seriously mentally ill patients, especially those admitted to DRFs, should familiarize 
themselves with the disclosure statutes and exceptions, including RSA 135-C:19-a. 
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WHO IS A PART 2 PROVIDER/PROGRAM? 
Let’s start by identifying who is a Part 2 “program”. Remember, the Part 2 regulations impose 
restrictions upon the disclosure and use of SUD patient records, which are maintained by a Part 2 
program.8 Once it is clear who is governed by this law, it becomes easier to understand how it 
differs from HIPAA and how it affects those Part 2 providers. In most instances, Part 2 is more 
restrictive than HIPAA. 
A Part 2 program can be any of the following individuals or entities:9 
• A Medical personnel or staff member who: 
o Holds themselves out as providing and does provide SUD treatment, 
diagnosis, or referral for treatment; or 
o Practices in a general medical facility whose primary function is SUD 
treatment, diagnosis, or referral for treatment and is identified as such; or 
o Is a NH Licensed Alcohol and Drug Counselor (LADC) providing LADC services; 
• An entity (other than a general medical facility) that holds itself out as providing and 
does provide SUD treatment, diagnosis, or referral for treatment; or 
• A unit within a general medical facility that holds itself out as providing and does 
provide SUD treatment, diagnosis, or referral for treatment. 
 
Note: A good question to ask is whether you hold yourself out as providing and do provide 
SUD services to patients. If you do, chances are you are a Part 2 provider and your records 
for SUD patients are protected by the heightened confidentiality obligations of Part 2. 
 
Example: Buprenorphine providers are not categorically included in the definition of a 
“Part 2 program,” unless the provider meets the “holds themselves out as providing” or the 
“primary function” test. 
 
Example: A family practitioner in a family practice screens a patient using SBIRT and refers 
the patient to a SUD provider for follow-up assessment. Conducting SBIRT does not make 













                                                             
8 42 C.F.R. § 2.2(a) (2017). 
9 42 C.F.R. § 2.11 (2017). 
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Note: The term “holds itself/themselves out as” is not actually defined anywhere in the law, 
but the Substance Abuse and Mental Health Services Administration (SAMHSA) 
commented on this phrase in its Frequently Asked Questions page regarding 42 CFR Part 2. 
SAMHSA states the phrase:  
“…could mean a number of things, including but not limited to state licensing procedures, 
advertising or the posting of notices in the offices, certifications in addiction medicine, 
listings in registries, internet statements, consultation activities for non-“program” 
practitioners, information presented to patients or their families, or any activity that 
would lead one to reasonably conclude that the provider is providing or provides 
alcohol or drug abuse diagnosis, treatment or referral for treatment.” (Emphasis added) 
SAMHSA, Applying the Substance Abuse Confidentiality Regulations, https://www.samhsa.gov/about-us/who-
we-are/laws/confidentiality-regulations-faqs, last visited May 17, 2017.  
See also 82 Fed. Reg. at 6065-6066. 
 
Part 2 applies to providers or programs that meet one of the definitions of a Part 2 program AND 
are federally assisted.10  
Federally Assisted Programs Are:11 
• Recipients of federal financial assistance; 
o Federal financial assistance is assistance of any kind, even if it does not directly 
fund the SUD treatment, diagnosis, or referral for treatment services. 
• Licensed, certified, registered, or authorized by the federal government to conduct 
business; 
• Tax-exempt through the IRS; or 
• Conducted by the federal government or a state or local government that receives 
federal funds, which could be used for SUD programs. 
• Exception: Part 2 does not apply to the Department of Veterans Affairs12 
                                                             
10 42 C.F.R. § 2.11 (2017). 
11 42 C.F.R. § 2.12(b) (2017). 
12 42 C.F.R. § 2.12(c) (2017). 
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DIFFERENCES BETWEEN PART 2 AND HIPAA13 
Now that we can identify Part 2 providers/programs, let’s take some time to differentiate Part 2 
from HIPAA. You are probably already familiar with HIPAA, but Part 2 works very differently so it 
is important to understand the differences between the two federal laws before moving forward. 
 HIPAA Part 2 
Who is 
Covered? 
1. Health care providers, 
both physical and 
behavioral health 
 
2. Health Plans 
 
3. Health care 
clearinghouses 
 
4. Business Associates 
1. An individual or entity (or a unit in a 
general medical facility or practice) 
that holds itself out as providing and 
does provide SUD treatment, 
diagnosis, or referral for treatment; 
OR 
 
2. Medical personnel or staff in a 
general medical facility or practice 
whose primary function is to provide 
such services and who are identified 
as SUD providers; AND 
 
3. Are federally funded 
 
[Note: providing SBIRT services does not 
necessarily make a provider a Part 2 
provider] 








• Psychotherapy notes 
documenting or 
analyzing a 
conversation during a 
private counseling 
session or group 
session must be 
maintained separately. 
Information, whether or not recorded, 
which: 
 
• Would identify a patient as a SUD 
patient either directly or by 
verification. 
 
• Is any SUD patient information 
created, received or acquired by a 
Part 2 program for the purpose of 
treating alcohol or drug abuse, 
making a diagnosis for treatment, or 
making a referral for that treatment. 
                                                             
13 42 C.F.R. § 2 (2017); 45 C.F.R. § 160, 162, and 164, (2009). 
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 HIPAA Part 2 
When is a 
disclosure 
permitted? 
• With a patient’s valid 
verbal or written 
authorization. 
 
• After a patient 
receives notice of the 
provider’s privacy 
policy, a covered 
provider may disclose 
health information 
without authorization 
for the purposes of 
treatment, payment, 
health care operations, 
and other purposes as 
consent authorizes. 
• When express written consent is 
given 
• For internal communications 
• For research 
• As part of an authorized record audit 
• When reporting child abuse/neglect 
• When the information is de-identified 
• By court order 
• In the event of a crime on program 
premises 
• In a medical emergency 
• Pursuant to a qualified service 
organization agreement 
 
[Note: re-disclosure is not allowed without 
consent of the patient.] 
Part 2 does not allow disclosures mandated by other state or federal laws unless a specific 
exception applies.  
 
Example: A state law requires all licensed health care providers to make their records 
available to state public health authorities for purposes of tracking communicable diseases. 
A Part 2 program is neither permitted nor required to disclose its Part 2 records for these 





Note: Part 2 does not allow a Part 2 
program to disclose Part 2 records for 
payment, treatment, or health care 
operations without consent. 
Note: Unlike HIPAA, oral consent to 
disclose information is NOT permitted by 
Part 2.  However, both written consents 
with signature and on-line consents with 
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Confidentiality and Minors 
Both HIPAA and Part 2 leave defining a minor, and whether a minor can obtain health care or 
alcohol/drug treatment without parental consent, entirely up to State Law. 
In New Hampshire a minor 12 years old or older may seek and be treated for drug dependency 
or any problem related to the use of drugs without parental consent.14 
Other issues regarding minors in NH 
• The age of majority in NH is 18.15 
• NH law provides that a health care provider can only perform an HIV test with the 
consent of the individual being tested.16 
o Example: If a 15-year-old is seeking any HIV test, that 15-year-old must consent 
to the test even if the parent does not consent. 
o Results of a test may only be given to the individual tested.17 
o If the individual tested is under 18 or lacks the mental capacity to understand a 
positive HIV test, the provider may disclose to the parent or guardian.18 
• A provider is not liable for failing to obtain consent when treating a patient in an 
emergency no matter the age of the patient.19 
• A minor who is 14 years old or older may seek and be treated for a sexually transmitted 









                                                             
14 N.H. Rev. Stat. Ann. § 318-B:12-a (2009). 
15 N.H. Rev. Stat. Ann. § 21-B:1 (1973). 
16 N.H. Rev. Stat. Ann. § 141-F:5 (2010). 
17 N.H. Rev. Stat. Ann. § 141-F:7, II (1995). 
18 N.H. Rev. Stat. Ann. § 141-F:7, III (1995). 
19 N.H. Rev. Stat. Ann. § 153-A:18 (1999). 
20 N.H. Rev. Stat. Ann. § 141-C:18 (1995). 
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WHAT PATIENT INFORMATION IS PROTECTED BY PART 2? 
It is important to identify a Part 2 program because the Part 2 programs are subject to the 
heightened confidentiality requirements of Part 2. It is also important to understand what records 
of a Part 2 program are protected. 
Part 2 protects against the “disclosure and use” of SUD “patient records” which are 




• A “patient” means any individual who has applied for or been given a diagnosis, 
treatment, or referral for treatment for a SUD at a Part 2 program (or someone who is 
identified as having a SUD after an arrest or charge).22 
 
• “Records” means any information relating to a patient received, created, or acquired by 
a Part 2 program, regardless of whether it is recorded or not.23 
 
• “Patient identifying information” includes anything that identifies the patient, such as 
name, address, Social Security number, or other information that allows for the 
identification of the patient.24  (It does not include a patient number, assuming the 
patient number does not contain patient identifying information like a Social Security 
number or a driver’s license number). 
 
• “Treatment” means the care or management of a patient suffering from a SUD, a 
condition identified as having been caused by the SUD, or both.25  
 
 
Note: If a patient’s SUD diagnosis or referral for treatment is NOT provided by a Part 2 




                                                             
21 42 C.F.R. §2.12(a) (2017). 
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• “Treating provider relationship” “means that regardless of whether there has been an 
actual in-person encounter: 
o a patient is, agrees to, or is legally required to be diagnosed, evaluated, and/or 
treated, or agrees to accept consultation, for any condition by an individual or 
entity, and 
o the individual or entity undertakes or agrees to undertake diagnosis, evaluation 
and/or treatment of the patient, or consultation with the patient for any 
condition.”26 (emphasis added) 
Example: The internal medicine practice of Your Health System conducts SBIRT screening 
and referrals, but does not provide SUD treatment, and refers a patient with SUD issues to 
the SUD Treatment Unit at the Community Mental Health Center.  The patient’s record 
maintained by the internal medicine practice, including the screening and referral, must 
comply with HIPAA and Your Health System’s privacy practices but not Part 2. However, 
the SUD Treatment Unit’s records will be protected by Part 2. 
 
Example: Part 2 confidentiality regulations do not apply to emergency room personnel 
who refer a patient to the intensive care unit for an apparent overdose, unless such 
personnel meet the definition of a Part 2 program or provider. 
 
Example: A pregnant patient of Your Community is screened by the OB nursing staff and is 
found to be at risk for substance abuse. The screening and referral are not considered Part 
2 records. Later, a provider from a well-advertised SUD Treatment Unit provides an 
assessment and recommendation for treatment, and schedules a follow-up visit. At that 
point, the records developed by the SUD Treatment Unit are protected by Part 2 and 
subject to heightened confidentiality. 
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WHEN CAN A PATIENT’S PART 2 RECORDS  
BE USED OR DISCLOSED? 
With a better understanding of the purpose of the law, how it differs from HIPAA, and who is 
considered a Part 2 Provider/Program and Patient, we next look at when Part 2 patient records 
CAN be disclosed. Good patient centered care and integrated patient care often depend upon the 
sharing of information! Remember, Part 2 regulations only permit disclosure of Part 2 records by a 
Part 2 program IF certain circumstance are present. The most relevant exceptions for integrated 
providers are disclosures pursuant to a written patient consent, disclosures to a qualified services 
organization, and disclosures in an emergency. 
The general rule under Part 2 is that SUD treatment records and information, including the 
identity of a SUD patient, cannot be disclosed. The limited exceptions to the general rule are 
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Proper Patient Consent 
 A patient can give consent to share their SUD treatment information. A Part 2 program 
may disclose Part 2 patient information if the patient has given valid written consent. 
For Part 2, consent is ONLY valid if it is in writing and meets the special requirements of 
Part 2. Written patient consents under Part 2 require more detail than an authorization 
under HIPAA. (See more on these requirements below)  
Internal Communications 
 Part 2 regulations do not apply to communications within a Part 2 program or between 
a program and an entity that has direct administrative control over that program, 
however, disclosure must be limited to those who have a “need for the information in 
connection with their duties that arise out of the diagnosis, treatment, or referral for 
treatment of patients with substance use disorders.”27 
Example: A patient tells his substance use counselor, at the Federally Qualified Health 
Center, that he has liver disease. The counselor can disclose the information to his 
supervisor, the care coordinator, social worker, and nurse to coordinate treatment needs. 
 
Example: A Part 2 program provider may discuss a compliance issue with the practice’s risk 
manager. 
 
Note: Remember any information disclosed with consent cannot be re-disclosed without 
further consent or an applicable exception. In the above situation, the compliance team 
would not be able to re-disclose the information unless it was reporting the information 






                                                             
27 42 C.F.R. § 2.12(c)(3) (2017). 
See Draft Form B in Appendix 
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Research and Audit 
 Research: Part 2 information may be disclosed, without patient consent, for the 
“purpose of conducting scientific research,”28 if certain protections are in place. Part 2 
information must be “rendered non-identifiable” in research reports.29 Records must 
still be maintained in compliance with other relevant federal, state, and local laws.30 
 
 
 Audit: Part 2 data may also be disclosed, without patient consent, for on-site audits or 
evaluations.31 Disclosures may be made to government agencies that help to fund or 
regulate the Part 2 program, private entities that help fund the program or provide 
third-party payments which are conducting quality control reviews, or others who are 
conducting an audit or evaluation of the program. Generally, entities must agree in 
writing to protect SUD patient records.32  
Reporting Suspected Child Abuse and Neglect 
 Part 2 providers must comply with relevant suspected child abuse and neglect laws and 
Part 2 allows for the disclosure of information for this purpose.33 Information may be 
disclosed for the initial abuse or neglect report, but restrictions on disclosure will still 
apply to SUD patient records that might be needed for future civil or criminal 
proceedings arising out of the initial report.34 
De-identified information 
 Part 2 is specifically meant to protect SUD patients from being identified as having or 
having had a SUD.35 Information that cannot be used to identify the patient as a 
current or past SUD patient may be disclosed as “de-identified” information. The new 
rules incorporate the detailed definition of “de-identified” applied by the HIPAA 
standards. 
 
                                                             
28 42 C.F.R. § 2.52 (2017). 
29 Id. 
30 Id. 
31 42 C.F.R. § 2.53 (2017). 
32 Id. 
33 42 C.F.R. § 2.12(c)(6) (2017). 
34 Id. 
35 42 C.F.R. § 2.12(a)(1) (2017). 
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Court Order 
 A Part 2 program may only disclose SUD patient information without consent by a 
court order if the court order complies with the heightened protections described in the 
law.36 Some of these requirements include:  
o Giving the Part 2 program (and the patient for noncriminal purposes) notice and 
opportunity to be heard before the court when a court order is requested;37 
o The use of fictitious names, confidential proceedings, sealed records, and 
limited disclosure of information to protect the patient’s SUD information;38 and 
o Heightened criteria for obtaining a court order which requires the court to find 
“good cause” for the order. The criteria include finding that “the public interest 
and need for the disclosure outweigh the potential injury to the patient, the 
physician-patient relationship and the treatment services,” including requiring 
that court orders for criminal cases be for crimes that are “extremely serious.”39 
Crime on Program Premises or Against Program Personnel 
 A Part 2 program can disclose certain information to law enforcement, without patient 
consent, if it relates to a patient committing or threatening to commit a crime on the 
program premises or against program personnel.40 Information that may be disclosed 
includes a report of the incident, patient status, name, address, and last known 
whereabouts of the person who committed or is threatening to commit the crime.41 
Example: After work, Counselor at a Part 2 program cannot find his car in the parking lot 
and there is shattered glass in the parking spot where he left his car. Earlier in the day, 
Patient X argued with Counselor and threatened to “mess” him up. Patient Y said he saw 
Patient X trying to break into the car. Part 2 allows the program to report to the police that 
the car has been stolen, the threat made by Patient X, Patient X’s name, address, status as 
a patient at the program, and last known whereabouts. The program cannot, however, 
disclose any information about Patient Y without her written consent. 
Legal Action Center, Tool #2, SBIRT and the Federal Alcohol and Drug Confidentiality Rules – The Basic 
Requirements, 6 (2017), https://lac.org/wp-content/uploads/2017/03/SBIRT_Tool2.pdf 
 
 
                                                             
36 42 C.F.R. § 2.64 (2017). 
37 42 C.F.R.  §§ 2.64 and 2.65 (2017). 
38 Id. 
39 Id. 
40 42 C.F.R. § 2.12(c)(5) (2017). 
41 Id. 
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Medical Emergency  
 Patient identifying information may be disclosed 
by a Part 2 program to medical personnel to the 
extent necessary to meet a bona fide medical 
emergency in which the patient’s prior consent 
cannot be obtained.42 
 Condition: The Part 2 program must document whom the information was disclosed to 
and who made the disclosure, the date and time of the disclosure, and the nature of the 
emergency (why the information was disclosed) in the patient’s record.43 
Example: If a Part 2 provider is meeting with a patient whom the provider believes might 
be dangerously intoxicated or overdosing, the provider can call for emergency services. If 
the patient loses consciousness or cannot give consent, the Part 2 provider can disclose the 
information to the emergency medical personnel, and the specific disclosure details must 
be documented later. 
Legal Action Center, Tool #2, SBIRT and the Federal Alcohol and Drug Confidentiality Rules – The Basic 
Requirements, 4 (2017), https://lac.org/wp-content/uploads/2017/03/SBIRT_Tool2.pdf 
 
Example: An emergency room physician is treating a patient in a medical emergency and 
contacts the patient’s treating provider to determine if the patient is on any medications. 
The treating provider appropriately discloses that the patient is on suboxone, as suboxone 
would impact anesthesia for the patient.  
Qualified Services Organizations 
A Qualified Services Organization (QSO) can share Part 2 information with a Part 2 program 
pursuant to a valid Qualified Services Agreement. A QSO is like a business associate, but be 
aware the definition of a QSO under Part 2 is much more limited than the delineation of a 
business associate under HIPAA. They are entities that provide services to the Part 2 program 
pursuant to a written agreement.44 QSOs can provide the following services:
• data processing  
• bill collecting 
• dosage preparation  
• lab analysis or 
 
                                                             
42 42 C.F.R. § 2.51 (2017). 
43 Id. 
44 42 C.F.R. § 2.11 (2017). 
45 Id. 
• professional services including 
o legal  
o accounting  
o medical staffing  
o population health management or  
o services to prevent or treat child abuse.45  
 
See Draft Form D in Appendix 
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How has this changed in the updated Part 2 law? The new Part 2 includes “population health 
management, medical staffing, or other professional services” in the language describing 
QSOs. This broadens the definition of a QSO and allows for disclosure to these entities 
pursuant to written agreement or patient consent. 
The QSO must enter into a written agreement with the Part 2 program and the agreement 
must acknowledge the QSO’s obligations to comply with the Part 2 regulations.46 The Part 2 
program can then share necessary information with the QSO. This means the Part 2 
restrictions on disclosures do not apply to communications between a Part 2 program and a 
QSO, but only to the extent the information disclosed is necessary for the QSO to provide 
agreed upon services to the Part 2 program.47 QSOs can include a third-party entity such as an 
electronic health record vendor, Health Information Exchange network, etc.48 
Example: Part 2 Unit enters into a QSO with affiliated Accountable Care Organization 
(ACO) staff to assist in the review of patient outcomes and quality indicators. Patient 




Note: A QSO CANNOT be used to “avoid obtaining patient consent in the treatment 
context.” (82 Fed. Reg. at 6067). For example, a practice cannot share Part 2 information 
with a specialist who is not part of the practice simply by entering into a QSO agreement. 
However, if the specialist provides services under a staffing agreement and treats patients 
at and through the practice part-time, a QSO is appropriate. SAMHSA warns, however, 
that a QSO agreement cannot be used to circumvent patient consent and disclose 
information to other treating providers outside the Part 2 program or unit such as PCPs, 
care managers, or medication management providers. (Id.) Disclosures by a Part 2 program 
to other practitioners outside the program usually requires patient consent. 
 
 
Example: A Part 2 program can enter into a QSO agreement with a locum tenens physician 
or community provider covering call for the practice. 
A Part 2 program can provide information to the QSO to the extent necessary for it to perform 
its services and the QSO can send that information back to the Part 2 program, but the 
information cannot be disclosed to a third party. In this instance a “third party” would be 
                                                             
46 Id. 
47 42 C.F.R. §§ 2.11 and 2.12(c)(4) (2017). 
48 Substance Abuse and Mental Health Services Administration, Frequently Asked Questions - Applying the 
Substance Abuse Confidentiality Regulations to Health Information Exchange (HIE), 
https://www.samhsa.gov/sites/default/files/faqs-applying-confidentiality-regulations-to-hie.pdf (last visited Aug. 
17, 2017). 
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someone not a member of the QSO agreement because there can only be 2 entities within 
such an agreement. Multi-party QSO agreements are prohibited.49  
Alternatively, a QSO agreement CAN be used to disclose information to an organization 
providing population health management services.50 However, these disclosures “would be 
limited to a specific office(s) or unit(s)/entity(ies) that is/are tasked with carrying out such 
services for the organization.”51 Thus, the information cannot be shared with the entire 
organization or its participants. 
 
PART 2 COMPLIANCE REQUIREMENTS 
Next, we will look more closely at the technical compliance steps required by Part 2 including: 
what types of policies and procedures a practice should have, when notice must be given, what is 
required for proper notice, what a consent must include, and what a non-re-disclosure notice must 
look like. 
If we break all of this down, there are 5 basic Part 2 requirements that need to be adhered to; 
those requirements are: 
I. Security Policies; 
II. Notice to Patients of Part 2 Rights; 
III. Patient consent forms that are compliant with Part 2; 
IV. Non re-disclosure notices when Part 2 information is disclosed; and 
V. Qualified Service Organization Agreements when necessary 
                                                             
49 Confidentiality of Substance Use Disorder Patient Records, 82 Fed. Reg. at 6067. Note, while multi-party QSOs 
are prohibited, multi-party consents are permitted. 

























QSOs will not be discussed further. Please refer back to pages 22-24 and see Draft Form D in Appendix for 
more information. 
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I. Security Policies and Procedures 
All Part 2 programs or holders of Part 2 information MUST have formal policies and procedures 
in place to reasonably protect against unauthorized uses and disclosures of patient identifying 
information.52 Policies and procedures must aim “to protect against reasonably anticipated 
threats or hazards to the security of patient identifying information.”53 These policies and 
procedures should be included in a practices general privacy policies and procedures. 
Paper 
Records54 
Policies and procedures for paper records must address the following: 
• Transferring and removing records; 
• Destroying records, including sanitizing the hard copy media associated 
with patient printouts, to render the patient identifying information non-
retrievable; 
• Maintaining records in a secure room, locked file cabinet, safe, or other 
similar container, or storage facility when not in use; 
• Using and accessing workstations, secure rooms, locked file cabinets, 
safes or other similar containers, and storage facilities that use or store 
such information; and 
• Rendering patient identifying information non-identifiable in a manner 





Policies and procedures for electronic records must address the following: 
• Creating, receiving, maintaining, and transmitting records; 
• Destroying records, including sanitizing the electronic media on which 
records are stored, to render the patient identifying information non-
retrievable; 
• Using and accessing electronic records or other electronic media 
containing patient identifying information; and 
• Rendering the patient identifying information non-identifiable in a 
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II. Notice of Patient Rights under Part 2 
 
Notice to patients of the federal confidentiality requirements MUST be given at the time of 
admission to the Part 2 program, or as soon thereafter as the patient has capacity.56 Notice of 
the federal law and regulations protecting privacy, a summary of the federal law and 
regulations, and the “required elements” set forth in Section 2.22 must be included. 57 The 
notice can include state law information as well.  
Notice must be in writing (either paper or electronic), and must:58 
 Communicate to the patient that their SUD patient records are protected by federal 
law and regulations, and 
 Include a summary of the federal law and regulations consistent with Part 2. 
 
Required Notice of Patient’s Rights: Elements of Section 2.22 
 
o A description of the limited circumstances that allow the patients information to be 
disclosed either by acknowledging their presence or identifying them as having or having 
had a SUD; 
o A statement that violation of Part 2 is a crime, suspected violations may be reported, and 
contact information for reporting violations; 
o A statement that information related to the commission of a crime on the premises or 
against personnel by a patient is not protected and may be disclosed; 
o A statement that reports of suspected child abuse and neglect are not protected and may 
be disclosed; 
o A citation to the federal law and regulations; and 




                                                             
56 42 C.F.R. § 2.16 (2017). 
57 42 C.F.R. § 2.22 (2017). 
58 42 C.F.R. §§ 2.22 and 2.11 (2017); 82 Fed. Reg. at 6077. 
See Draft Form A in Appendix 
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III. Compliant Patient Consents 
 
A Part 2 program may disclose patient information 
if the patient has given valid written consent. For 
Part 2, consent is ONLY valid if it is in writing. A 
valid written consent form must include the 
following elements:59  
o From Whom: Identify the Part 2 
program as the entity making the 
disclosure; 
o What Kind: Describe “how much” 
and “what kind” of treatment 
records will be disclosed; 
o Purpose: Describe the purpose of 
the disclosure; 
o To Whom: Clarify “to whom” the 
disclosure will be made (Important, 
see details below); 
o Right to Revoke: Let the patient 
know of his/her right to revoke; 
o Expiration: Identify a date the 
consent expires – (this can be longer than a year!); and 
o Signature: Be signed and dated by the patient - (this can be an electronic 
signature).  
                                                             
59 42 C.F.R. § 2.31 (2017). 
See Draft Form B in Appendix 
How has this changed in the updated 
Part 2 law? 
The new Part 2 regulations changed 
the “To Whom” requirements to allow 
for general designations of treating 
providers. A patient may now give 
written consent to allow disclosure 
information to “all my treating 
providers” at a specifically named 
practice or medical facility. For 
example, a consent may designate “to 
an HIE and all my treating providers,” 
or an ACO and “all my treating 
providers.” See below for more 
details. 
Confidentiality of Substance Use Disorder 
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 From Whom: Integrated providers must identify the Part 2 
program providers in their delivery network. The Part 2 
program providers are the ones that create protected Part 2 
information. Part 2 providers are responsible for securing 
consents and otherwise protecting the patient’s Part 2 
information. The Part 2 program or other entity making the 
disclosure must be identified in the written consent. 
 
 What Kind: The patient must be told “how much” and “what kind” of SUD records will be 
disclosed. It must be clear to the patient what SUD information will be included. Disclosing 
providers should consider what needs to be disclosed for purposes of integrated care and 
treatment. 
 
 Purpose: The patient must be told for what purpose the information will be disclosed. 
Providers should also assess why the information must be shared. 
 
 To Whom: Identifying “to whom” the disclosures will be made is an important part for Part 
2 confidentiality compliance. Part 2 providers must assess patient flows and care patterns 
to best determine in advance “to whom” information should be shared in an integrated 
care setting.  
o The consent form must provide information about “to whom” the patient information 
will be disclosed. 
 The form CAN name the ENTITY:60 
• If disclosure is to a treating provider 
• If disclosure is to treating providers through an intermediary or a Health 
Information Exchange (HIE) 
o However, the intermediary or HIE must provide the patient with a list 
of the entities to whom Part 2 records are provided if requested. 
• If disclosure is to a third party payer 
Example: I consent to disclosing my patient record including my mental health and SUD 
information to my treating providers at Primary Care Practice X and Hospital Y. 
o The form MUST name the INDIVIDUAL: 
 If the recipient entity does not have a treating provider relationship with the 
patient.61 
Example: I consent to disclosure and confirmation of my attendance at and adherence to my 
treatment plan with Andy White my parole officer and Patricia Black my care manager at City 
Supported Housing. 
                                                             
60 42 C.F.R. § 2.31 (a)(4) (2017). 
61 42 C.F.R. § 2.31(a)(4)(iii)(B) (2017). 
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 Right to Revoke: The patient must be informed that they have a right to revoke their 
consent. 
 
 Setting expiration dates for consent: The consent form must have a date, event, or 
condition which will trigger the expiration of the consent, if it has not already been 
revoked.62 The form cannot just say that consent is valid until revoked.63 It must specify an 
event, condition, or date. However, an expiration date stated as “upon my death” is proper 
and consent may last longer than a year.64 
 




                                                             
62 42 C.F.R. § 2.31(a)(4)(iii)(B) (2017). 
63 82 Fed. Reg. at 6078. 
64 Id. 
The patient’s right to a list of entities to whom information has been disclosed. (42 C.F.R. 
§ 2.31 (2017).) 
Patients may consent to disclose information to treating providers at certain generally 
designated entities. For example, “I authorize disclosure of my substance use disorder 
records to my treating providers through the information exchange.” The information 
exchange is then the “intermediary.” 
The patient must be informed that “upon their request” and consistent with Part 2, “they 
must be provided a list of entities to which their information has been disclosed." (42 C.F.R. 
§ 2.31 (2017). * 
Patient Right to List of Disclosures (42 C.F.R. § 2.13 (2017).) 
• The intermediary or “Health Information Exchange,” (not the Part 2 program) is 
responsible for giving the patient a list of entities to whom it disclosed Part 2 records. 
o Upon written request by the patient, the intermediary must provide, within 30 days 
of the request: 
 A list of entities to whom information was disclosed 
 Descriptions of what information was disclosed and when 
 Dating back for the last 2 years  
* There are special rules in New Hampshire regarding disclosure of protected health information through Health 
Information Exchanges/Organizations. If you use an HIE/HIO you should familiarize yourself with the 
requirements of N.H. Rev. Stat. Ann. § 332-I:3 (2014). 
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IV. Prohibition against Re-Disclosure 
 
EVERY disclosure made pursuant to a consent MUST include the special non-disclosure 
language that follows:65 
ALCOHOL OR DRUG ABUSE TREATMENT REDISLCOSURE PROHIBITED 
 
“This information has been disclosed to you from records protected by federal 
confidentiality rules, 42 CFR Part 2.  The federal rules prohibit you from making any 
further disclosure of information in this record that identifies a patient as having or 
having had a substance use disorder either directly, by reference to publicly 
available information, or through verification of such identification by another 
person unless further disclosure is expressly permitted by the written consent of the 
individual whose information is being disclosed or as otherwise permitted by 42 CFR 
Part 2. A general authorization of the release of medical or other information is 
NOT sufficient for this purpose (see 2.31). The federal rules restrict any use of the 
information to investigate or prosecute with regard to a crime any patient with a 
substance use disorder, except in connection with a crime committed on the 
premises or against a SUD provider, or consistent with 42 CFR Part 2 section 2.65.” 
Note: Persons or entities who have received SUD patient information are not allowed to re-
disclose that information to someone else without specific consent or unless an applicable 
exception applies. 
The regulators have promised to review this complicated and lengthy “Prohibition Against Re-
Disclosure” language to determine whether a shorter form is appropriate. Incorporating this 
language each time there is a use or disclosure pursuant to a consent is a challenge in the 
integrated setting, but can and must be incorporated appropriately into practice flow patterns. 
                                                             
65 42 C.F.R. § 2.32 (2017). 
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 Who are your Part 2 providers or “units” who create confidential records? 
 Who are your Part 2 patients who must sign Part 2 consents? 
 Assess your practice patterns in order to determine “to whom” and “from whom” 
consent needs: 
o What entities/providers do Part 2 providers share information with? 
o What behavioral health care entities/providers do providers need information 
from? 
 Review your policies and patient consent forms and adapt to integrated care model. 
 Provide patients with appropriate Notice of federal confidentiality requirements at the 
time of treatment if possible.66 
 How will you ensure non-re-disclosure language provided each time Part 2 information 
is disclosed? 
 Assess your electronic health record (EHR) capabilities. 
Classifying “To Whom?” 
 Is the disclosure of Part 2 information by a Part 2 program to the individual protected 
because: 
o Internal Communications? 
o By Consent? 
o QSO? 
o Other exception? 
 Is the individual/entity part of the Part 2 Program? 
 If a treating provider, are the providers or care coordinators providing services as part of 
the Part 2 program or are they employed by a separate entity? 
 Is the individual or entity providing staffing or other services to the Part 2 Program? 
 Is the individual/entity providing the type of services to the Part 2 program listed in the 
rules? 
 Does the individual/entity need to see Part 2 information? 
We have now discussed the major changes to Part 2. We hope you have a better understanding 
now of how the law has changed and what your entity must do to comply with the new law and 
regulations. The rest of this workbook contains helpful resources to assist you in your process of 
making sure your forms and procedures comply with the new Part 2 in your integrated care 
setting. 
                                                             
66 42 C.F.R. § 2.22 (2017). 
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PRE-WORK AND BOOT CAMP SESSIONS 
Pre-Work: Conduct IDN Project Scan 
Task: Identify IDN Project Plans where projects necessitate, or are anticipated to necessitate, 
the provision or sharing of substance use treatment records of DSRIP attributed patients. 
 Treating and non-treating professionals or entities who are participating directly in the 
Project. 
 Anticipated role of the participating entities/individuals. 
 What information will be shared amongst Project team entities/professionals including 
specifically what SUD treatment/diagnosis/referral records will be shared? 













X  X   
Sample: Your 
CMHC, Inc. 
 X    
      
      
      
 
Purpose of Scan: To develop appropriate detail for purposes of Part 2 “Scan” in order to 
identify Part 2 providers, Part 2 records, and Part 2 patient flow.  We need the answers to these 
questions in order to:  
 Determine when privacy “packet” (consents/privacy notice) needs to be reviewed with 
SUD patient and by whom 
 Determine how to complete the model “to whom” language of the patient consents 
 Determine purpose for which records will be shared for purposes of Part 2 compliance 
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APPENDIX 
Guidelines for completing process flow of IDN Projects 
Process Flow Map 
Guidelines for completing Part 2 Consents 
From/To Whom Chart for Disclosures 
Classifying Your Organization’s Help and Support 
Instructions for FORM Development 
Form B with Instructions 
Form A- Sample Notice of Privacy Practice 
Form B- SUD Services: Authorization and Consent to Disclose 
Form C- Prohibition on Re-disclosure Language 
Form D- QSO Agreement 
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GUIDELINES FOR COMPLETING PROCESS FLOW OF IDN 
PROJECTS 
 
Answer each of the questions below while visually creating a process flow map (see 
template below) to identify Part 2 patients and providers/entities. 
 
1. Identify what Part 2 Substance Use Disorder (SUD) Service you are improving, 










2. Identify a Part 2 Patient in this Project. For this exercise, we will be using Aster. 
Aster represents a person who through entering into this project is identified as an individual 
with a substance use disorder. 
 
 
3. Identify who will recommend Aster for this project service (i.e. PCP, county courts, etc.). 
Use a box per entity in the corresponding section. 
 
 








c. Are they a community organization? 
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Using the key and supplies provided to you, identify the entities you classified for the 
above questions. If the recommender is NOT a treating provider, identify by name. 
Follow the instructions for further detail. 
 




a. What SUD/Part 2 information needs to be shared by this entity with the 





b. Two-way information sharing or one-way sharing? Identify relationship with 














b. Two-way information sharing or one-way sharing? Identify relationship with 
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GUIDELINES FOR COMPLETING PART 2 CONSENTS 
 
 
1. What are you doing together as IDN partners with other individuals or entities 
that necessitates disclosure of patient behavioral health information?  




2. Which SUD/Part 2 or lawful holder of SUD/Part 2 information in your Project patient flow 
will be reviewing confidentiality issues with the patient and when? (i.e. securing the 
consent, reviewing privacy notice, etc.) 
 









3. What type of SUD/Part 2 information will be disclosed to other providers, entities or 
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4. To whom will the disclosures be made? 
 




b. Non-Treating Providers: Name the entities or individuals who are NOT treating 
providers to whom SUD/Part 2 information will be disclosed? If you do not know the 






c. Name the intermediary, such as an information exchange, if you may be using to 





d. Will any of the providers, entities and/or individuals who receive the SUD/Part 2 




5. Which entity or individuals will be involved in population health/evidence-based 
outcome analysis with regard to the SUD patients included in this project? Briefly 
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Draft 2017- For Reference Purposes Only   
For Use and Review by IDNs Participating in UNH Privacy Boot Camp 
SAMHSA has promised but has not yet published sub-regulatory guidance or draft Forms consistent with the 42 CFR 
Part 2 regulations published January 2017. Any Form should be reviewed with and revised by your provider’s 
leadership/compliance team and counsel as necessary. 
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INSTRUCTIONS FOR FORM DEVELOPMENT EXERCISE 
 
1. Draft Forms:  
Please review the PowerPoint presentations and Workbook for further information 
about the requirements of 42 CFR Part 2, as amended. The rules require: 
1. Formal Policies and Procedures to secure Part 2 information (2.16) 
2. Notice of Privacy Rights (adapted and updated from Legal Action Center form 
published pre-2017) (Draft Form A attached) 
3. Consent/Authorization to Disclose (Draft Form B attached) 
4. Prohibition on Re-disclosure language – to be attached to Part 2 information that 
is disclosed pursuant to a consent (adapted from 42 CFR Part 2) (Draft Form C 
attached) 
5. Qualified Services Organization Agreement template language (adapted and 
updated from Legal Action Center forms published under rules pre-2017) (Draft 
Form D attached) 
2. Notice of Privacy Rights (Draft Form A): 
a. To be provided to patients as soon as practicable by a Part 2 Program provider. 
b. Draft Form A includes basic requirements of the statute. 
 
3. Consent/Authorization (Draft Form B):  
a. The basic elements of a 42 CFR Part 2 consent are listed below and a general 
form template with instructions is attached for your use and adaptation. Many 
Part 2 providers have authorization forms and consents already in use that may 
be modified to incorporate updated language.  The consent/authorization 
language should be consistent with your program’s philosophy, the IDNs 
purpose, whole person patient care and privacy compliance.  Confidentiality 
should not overwhelm good patient care – it should be part of it: 
 
• Name of Patient 
• Name of Part 2 Program making the Disclosure 
• Identification of TO WHOM the disclosure will be made 
o Treating providers 
o Community Care Agencies or other non-treating providers 
o Payers 
o Health Information Exchange (if needed) 
o friends and family members (if needed) 
Draft 2017- For Reference Purposes Only   
For Use and Review by IDNs Participating in UNH Privacy Boot Camp 
SAMHSA has promised but has not yet published sub-regulatory guidance or draft Forms consistent with the 42 CFR 
Part 2 regulations published January 2017. Any Form should be reviewed with and revised by your provider’s 
leadership/compliance team and counsel as necessary. 
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• Identify WHAT will be disclosed 
• Identify the PURPOSE for the disclosure 
• Right to revoke 
• Effective date and expiration date 
• Reminder of 42 CFR Part 2 Rights in general 
 
We recommend you try to fill out a consent form together using the template provided.  
Compare this to the forms you are currently using.  Modify and update as necessary.  
 
4. Prohibition on Re-Disclosure Statement (Draft Form C): 
a. To be provided to any recipient of Part 2/SUD information when disclosed by a 
Part 2 provider or re-disclosed by an authorized recipient pursuant to a consent.  
b. Draft Form C includes language directly from Part 2 regulations.  
 
5. Qualified Service Organization Agreement (Draft Form D): 
a. See PowerPoint exercise from July 17, 2017. 
b. Draft Form D includes examples of suggested language required by 42 CFR Part 
2. 
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SUBSTANCE USE DISORDER SERVICES: 
AUTHORIZATION AND CONSENT TO DISCLOSE PROTECTED HEALTH 
INFORMATION67,68 
DRAFT FORM B WITH INSTRUCTIONS 
 
 
Name: ________________________________________ Date of Birth:_____________ 
 
Medical Record # (if known):______________________ 
 
 
[Introduction FROM WHOM: Describe IDN integrated treatment model and identify the Part 2 
Program making the disclosures. An example is provided below:]69  
 
I understand my care providers at [Name of SUD/Part 2 ENTITY making 
disclosure]______________________[If part of hospital system, include affiliated entities if 
necessary, i.e., “I am a patient of Mount Ida Primary care, Mount Ida Capital partners and 
affiliated entities”] will be providing and helping to coordinate aspects of my care and 
treatment and will therefore need to share certain private health information about my 
referral, diagnosis and/or treatment for substance use disorder [and mental health] with my 
treatment team, with other treating providers, with other individuals or entities involved in my 
care and/or recovery, with entities responsible for payment and with others listed below as 
authorized by me or by law.   
 
  
                                                             
67 Acknowledgement: UNH Health Law and Policy appreciates the collaboration of the Legal Action Center 
(Deborah Reid, JD), the New Hampshire Center for Excellence (Amy Pepin) and New Hampshire attorneys also 
assisting providers in 42 CFR Part 2 compliance, including, but not limited to Courtney Grey Tanner, JD, MSW, NH 
Providers’ Association, Sabrina Dunlap, JD, HinkleyAllen and Jason Gregoire, JD, Sheehan Phinney Bass & Green.  
68 NOTE: This Sample Consent Form may be used separately from or combined with a provider’s HIPAA form, 
however, HIPAA differs from 42 CFR Part 2 in that HIPAA applies to all “covered entities” disclosing private health 
information, whereas Part 2 applies to Part 2 Programs.  
69 NOTE: The 42 CFR Part 2 rules apply heightened confidentiality restrictions to disclosures and re-disclosure of 
SUD/Part 2 information by Part 2 Programs (SUD Providers).   This Sample Consent Form is intended for use with 
SUD patients referred for SUD services from SUD/Part 2 providers. Non-SUD health care providers may make 
disclosures consistent with applicable privacy rules or regulations to the extent they apply, such as HIPAA.  
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[Section 1: For Disclosures to Treating Providers70] 
 
[WHAT]: 
I authorize [my Part 2 Program treatment team]71 to access, use, disclose and communicate 
both verbally and in writing, private substance use disorder and mental health information 
[which is maintained as part of my integrated electronic health record]72, including:  
[Check all that apply]73 
 
☐ My health care record 
☐ Intake, progress and discharge reports and notes  
☐ Evaluations and assessments by my providers 
☐ Test, lab and radiology results 
☐ Referrals for treatment 
☐ Medications 

















                                                             
70 NOTE: Consent must be obtained from a patient in order for a Part 2 Program to share SUD/Part 2 information 
with treating providers (other than those in the Part 2 Program or unit). A “treating provider” is an individual or 
entity that provides health related assistance to a patient by way of diagnosis, evaluation or treatment.  
71 NOTE: There is no consent required for sharing a SUD patient’s identity and SUD/Part 2 information amongst 
the Part 2/SUD Program’s own treating providers.  
72 NOTE: Part 2 Programs that are part of a larger health system and use a unified EHR should work with their 
compliance team and EHR vendor to manage the consent and prohibition against re-disclosure notice process.  
73 NOTE: In developing your consent form, you may summarize if all treating providers will have access to the 
medical record for purposes of their treatment. 
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[TO WHOM and PURPOSE] 
I understand disclosures and re-disclosures both verbally and in writing may be made to and 
from my past, current and/or future treating providers for the purpose of my ongoing 
treatment and recovery and helping me manage my care, including but not limited to:74 [LIST 
OF TREATING PROVIDER ENTITIES] 
[Check all that apply]75 
 
☐ My Care Coordinator(s) at76: ________________________________________ 
☐ [IDN Treating Provider Entity 1] 
☐ [IDN Treating Provider Entity 2] 
☐ [IDN Treatment Provider Entity 3] 
☐ [IDN Treatment Provider Entity 4] 
☐ [IDN Treatment Provider Entity 5] 
☐ [IDN Treatment Provider Entity 6] 
☐ [IDN Treatment Provider Entity 7] 
☐ [My treating providers through the [Health Information Exchange]]: (Name/Title of 
Supervisor of HIE) ________________________________________________ 
☐ Other: (specify) __________________________________________________ 
☐ Other: (specify) __________________________________________________  
                                                             
74 NOTE: The new Part 2 rules explain that Part 2 Providers can seek consent to disclose generally to “treating 
providers” through an “intermediary.”  The intermediary, whether it be a medical facility or Health Information 
Exchange (HIE), must keep track of disclosures and provide the list to the patient upon request.  Part 2 Programs 
can include a specific consent to disclose to treating providers through a HIE and provide the explanation in the 
Notice of Privacy Practices.  If the intermediary is a clinic or hospital, the clinic or hospital must keep track of 
disclosures. If the intermediary is a HIE, as a non-treating provider intermediary, the person responsible for the 
HIE must be named.  
75 NOTE: IDN teams should consider listing by entity name the treating providers that are part of a typical SUD 
patient’s “patient flow” as documented in the first day of Boot Camp. When filling out the consent form, the 
treating providers can be checked. If the SUD/Part 2 program is part of an integrated medical system, the Part 2 
Program affiliates should be listed.  
76 NOTE: Care coordinators do not have to be listed at all if they are part of the Part 2 Program team, or the care 
coordinator can be described and listed as a treating provider or as a non-treating provider identified by name 
depending upon how the care coordination function is set up by the IDN or group of providers. 
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[Section 2: List of Community Care Agencies and Other Non-Treating Providers]77:  
 
[WHAT]: 
I also authorize [my treatment team] to access, use, disclose and communicate both verbally 
and in writing the following private substance use disorder and mental health information 
[which is maintained as part of my integrated electronic health record], including:78 
[Check all that apply] 
 
☐ My medical events, care management plan and medication list 
☐ My attendance at my recovery program 
☐ Information confirming my compliance with my care and recovery plan 
☐ Other: ___________________________________________________ 
☐ Other: ___________________________________________________ 
 
[TO WHOM and PURPOSE]79 
I understand that disclosures and re-disclosures may be made both verbally and in writing to 
and from the following individuals involved in my well-being and recovery: 
  
[LIST OF NAMES AND TITLES of individuals at COMMUNITY CARE AGENCIES or other non-
treating providers to whom SUD/Part 2 Program Information will be disclosed] 
 
☐ Agency: (Title/Name of Individual/Tel #) _________________________________ 
☐ Agency: (Title/Name of Individual/Tel #) _________________________________ 
☐ Agency: (Title/Name of Individual/Tel #) _________________________________ 
☐ Agency: (Title/Name of Individual/Tel #) _________________________________ 
☐ Other: _____________________________________________________________ 




                                                             
77 NOTE: “Community Care Agencies” are simply those partners who will be part of the patient’s care “flow” in the 
IDNs who do not provide medical care, such as police departments, DCYF, housing services, vocational rehab, etc.  
Consents to share SUD/Part 2 information with community care agencies must identify the name of the person to 
whom the disclosure will be made. 
78 NOTE: Create either an opt in or opt out list of the specific information your Part 2/SUD program might share 
with Community Care Entity 
79 NOTE: If possible, to be consistent with the Part 2 rules, the purpose of the disclosure should correspond with 
the name of the individual to which it is disclosed, e.g., “Laconia PD, Officer True” for “confirming compliance 
with court ordered treatment, probation or parole”.  
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For the purpose of: [check all that apply] 
 
☐ Monitoring and supporting my ongoing recovery 
☐ Assessing/evaluating my readiness/ability to participate in 
housing/employment/vocational training 
☐ Confirming compliance with court ordered treatment, probation or parole 





[Section 3: For Payment]:80 
 
I authorize [my treatment team] to use, disclose and communicate both verbally and in writing 
any and all information about my care and treatment to and from my health insurance 
company or other entity responsible for my medical bills for the purpose of eligibility and 
payment. [Either insert the name of the payer or refer to your program’s policy regarding 




Authorization to Discuss Health Status with Family, Friends and/or Advocates  
If I am not present or available, I authorize [ENTITY] affiliated treating providers and staff to 
discuss my relevant health information, including my substance use disorder [and mental 
health] treatment, with the family members, friends and/or advocates named below. 
 
 Authorized individuals (please provide full names): 
Name: _____________________________________ Tel # _________________________ 
Name: _____________________________________ Tel # _________________________ 
Name: _____________________________________ Tel # _________________________ 
Name: _____________________________________ Tel # _________________________ 
Name: _____________________________________ Tel # _________________________ 
Name: _____________________________________ Tel # _________________________ 
 
                                                             
80 NOTE: Your Part 2 Program may simply modify its existing form or policy requesting information about payer 
sources, confirming the ability to disclose SUD information to the payer on the form consistent with 42 CFR Part 
2. 
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Acknowledgement of Rights 
I understand that my substance use disorder treatment records are protected under the federal 
regulations governing Confidentiality and Drug Abuse Patient Records, 42 C.F.R. Part 2, and the 
Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), 45 C.F.R. pts 160 & 164, 
and cannot be disclosed without my written consent unless otherwise provided for by the 
regulations. I understand that if my treating providers disclose my substance use disorder 
treatment records pursuant to this consent, the recipient will be provided a notice of non-
disclosure.  
 
I also understand that I may revoke this consent, orally or in writing by contacting 
[APPROPRIATE ENTITY INFORMATION MANAGEMENT 
OFFICE_____________________________] at [PHONE NUMBER______________] at any time 
except to the extent that action has been taken in reliance on it. We are unable to take back 
any disclosures we have already made with your consent and we are required to retain as 
records of the care we provide to you.  
 
If not already revoked, this consent will expire on __________________ [Example: One 
year/specified date/upon my death.]  
 
Upon request, I can inspect or obtain a copy of the information I am authorizing to be released.  
 
[I understand that I may be denied services if I refuse to consent to a disclosure for purposes of 
my treatment [or payment]. I will not be denied services if I refuse to consent to a disclosure for 
other purposes.]81 
 
If I have any questions about disclosure of my private health information, I can contact 
_________________ at [PHONE NUMBER]. 
 
I understand I can ask for a copy of this authorization and consent form.  
   
 
_________________________________________________________  ____________ 
Signature of Patient or legal representative or guardian    Date and Time 
 
 
_________________________________________________________   
Authority/Relationship of representative to patient      
(Attach copy of documentation of authority) 
                                                             
81 This provision is not necessary and may be different depending upon the type of provider offering services.  
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NOTICE OF PRIVACY PRACTICES FOR SUBSTANCE USE PATIENTS  
DRAFT FORM A 
 
As a patient receiving substance use disorder prevention and treatment services by our 
Substance Use Disorder Treatment staff at [PART 2 PROGRAM ENTITY/ENTITIES] or an affiliated 
provider, your treatment records have additional privacy protections under federal law. Private 
information regarding your health and substance use disorder care is protected by two federal 
laws including HIPAA, and what we refer to as “Part 2.”  The full description of these laws are: 
the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), 42 U.S.C. § 1320d et 
seq., 45 C.F.R. Parts 160 & 164, and the Confidentiality of Substance Use Disorder Patient 
Records, 42 U.S.C. § 290dd, 42 C.F.R. Part 2 (“Part 2”). Specifically, Part 2 includes 
confidentiality provisions relating to the access, use, and disclosure of substance use disorder 
patient records. These protections go above and beyond the protections described in our 
[ENTITY] Notice of Privacy Practices. 
 
Under Part 2, you must give written consent before information identifying you as a patient 
who needs or is receiving substance use disorder prevention and treatment is disclosed, 
including to entities or individuals who are paying your insurance claims. We ask you to help us 
care for you and support your treatment goals by providing a written consent that allows your 
providers to receive from, and disclose to, other treating providers, your identity and 
information in order to provide you the care you need, to obtain payment for care and 
treatment, and to allow for communication with other professionals, friends, and advocates 
involved in your treatment or recovery.  
 
Under federal law, we may disclose information about your care and treatment for substance 
use disorder services without your written consent for the following reasons:  
 
1) The disclosure is allowed by court order; 
2) The disclosure is made to medical personnel in a medical emergency; 
3) The disclosure is made to appropriate authorities to report suspected child abuse or 
neglect; 
4) The disclosure is made to a qualified service organization/business associate; 
5) The disclosure is made to qualified personnel for research, audit or program 
evaluation; or 
6) The disclosure is made in connection with a suspected crime committed on the 
premises or a crime against any person who works for us or about any threat to 
commit such a crime.  
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For example, [ENTITY/ENTITIES] or an affiliated provider can disclose information without your 
consent in order to provide services in a medical emergency to ensure your emergency is 
treated effectively.  
In addition, with your consent, the [Part 2 Program] will disclose [your treatment and recovery 
information] [your medical events, a shared care plan, and your medication list] to your treating 
providers using a confidential and secure information exchange [identify HIE]. You have a right 
to request a list of the treating providers who have received your substance use disorder 
treatment information exchanged by [the HIE] pursuant to 42 CFR Part 2. If you would like 




Violation of Part 2 is a crime and suspected violations may be reported to appropriate 
authorities, including the US Attorney in the judicial district where the violation occurs.  
 
If you have any questions about disclosure of your private health information, you can contact 
[APPROPRIATE ENTITY INFORMATION MANAGEMENT OFFICE] at [PHONE NUMBER]. 
Acknowledgement of Receipt of the [ENTITY] Notice of Privacy Practices by Substance 
Use Patients   
  
I acknowledge that I have received and reviewed the [ENTITY] Notice of Privacy Practices for 
Substance Use Patients, which includes particular information relating to the disclosure and use 
of information relating to substance use treatment (entitled Notice of Privacy Practice 
Substance Use Patients).   
Name/DOB: ________________________________/_____________ Date: ____________  
                                                             
82 NOTE: SAMHSA will be issuing sub-regulatory guidance on the responsibility of an intermediary to provide a 
“list” of disclosures, including clinics or practices who are sharing information with treating providers pursuant to 
a general consent.  The obligations of an HIE to provide a list are clearly indicated in the comments to the rule and 
therefore included in this draft FORM for Notice of Privacy Rights. General or multi-specialty practice entities who 
receive Part 2 information pursuant to a consent pursuant to the “treating provider” designation may also have an 
obligation to notify the patient upon request which treating providers at the receiving entity access the patient’s 
SUD records under the new Part 2 rules.  Please consult with your attorneys or compliance team regarding this 
obligation and regulatory guidance as it is provided by SAMHSA in the near future.  
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SUBSTANCE USE DISORDER SERVICES: 
AUTHORIZATION AND CONSENT TO DISCLOSE PROTECTED HEALTH 
INFORMATION83 
DRAFT FORM B 
 
Name: ________________________________________ Date of Birth:_____________ 
 
Medical Record # (if known):______________________ 
 
 
I understand my care providers at [Name of SUD/Part 2 ENTITY making 
disclosure]______________________[If part of hospital system, include affiliated entities if 
necessary, i.e., “I am a patient of Mount Ida Primary care, Mount Ida Capital partners and 
affiliated entities”] will be providing and helping to coordinate aspects of my care and 
treatment and will therefore need to share certain private health information about my 
referral, diagnosis and/or treatment for substance use disorder [and mental health] with my 
treatment team, with other treating providers, with other individuals or entities involved in my 
care and/or recovery, with entities responsible for payment and with others listed below as 
authorized by me or by law.   
 
I authorize [my Part 2 Program treatment team] to access, use, disclose and communicate both 
verbally and in writing, private substance use disorder and mental health information [which is 
maintained as part of my integrated electronic health record], including:  
[Check all the apply] 
 
☐ My health care record 
☐ Intake, progress and discharge 
reports and notes  
☐ Evaluations and assessments by 
my providers 
☐ Test, lab and radiology results 
☐ Referrals for treatment 
☐ Medications 
☐ Case management and treatment plans 
(including addendums) 
☐ Other: (specify) 
___________________________________ 
☐ Other: (specify) 
___________________________________ 
 
                                                             
83 Acknowledgement: UNH Health Law and Policy appreciates the collaboration of the Legal Action Center 
(Deborah Reid, JD), the New Hampshire Center for Excellence (Amy Pepin) and New Hampshire attorneys also 
assisting providers in 42 CFR Part 2 compliance, including, but not limited to Courtney Grey Tanner, JD, MSW, NH 
Providers’ Association, Sabrina Dunlap, JD, HinkleyAllen and Jason Gregoire, JD, Sheehan Phinney Bass & Green. 
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I understand disclosures and re-disclosures both verbally and in writing may be made to and 
from my past, current and/or future treating providers for the purpose of my ongoing 
treatment and recovery and helping me manage my care, including but not limited to:  
[Check all that apply] 
 
☐ My Care Coordinator(s) at: _________________________________________ 
☐ [IDN Treating Provider Entity 1] 
☐ [IDN Treating Provider Entity 2] 
☐ [IDN Treatment Provider Entity 3] 
☐ [IDN Treatment Provider Entity 4] 
☐ [IDN Treatment Provider Entity 5] 
☐ [IDN Treatment Provider Entity 6] 
☐ [IDN Treatment Provider Entity 7] 
☐ [My treating providers through the [Health Information Exchange]]: (Name/Title of 
Supervisor of HIE) _________________________________________________ 
☐ Other: (specify) ___________________________________________________ 
☐ Other: (specify) ___________________________________________________ 
 
I also authorize [my treatment team] to access, use, disclose and communicate both verbally 
and in writing the following private substance use disorder and mental health information 
[which is maintained as part of my integrated electronic health record], including: 
[check all that apply] 
 
☐ My medical events, care management plan and medication list 
☐ My attendance at my recovery program 




I understand that disclosures and re-disclosures may be made both verbally and in writing to 
and from the following individuals involved in my well-being and recovery:   
 
☐ Agency: (Title/Name of Individual/Tel #) __________________________________ 
☐ Agency: (Title/Name of Individual/Tel #) __________________________________ 
☐ Agency: (Title/Name of Individual/Tel #) __________________________________ 
☐ Agency: (Title/Name of Individual/Tel #) __________________________________ 
☐ Other: _____________________________________________________________ 
☐ Other: _____________________________________________________________ 
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For the purpose of: [check all that apply] 
 
☐ Monitoring and supporting my ongoing recovery 
☐ Assessing/evaluating my readiness/ability to participate in 
housing/employment/vocational training 
☐ Confirming compliance with court ordered treatment, probation or parole 
☐ For the purpose of the care and treatment of my children 
☐ Other: ____________________________________ 
☐ Other: ____________________________________ 
 
I authorize [my treatment team] to use, disclose and communicate both verbally and in writing 
any and all information about my care and treatment to and from my health insurance 
company or other entity responsible for my medical bills for the purpose of eligibility and 
payment. [Either insert the name of the payer or refer to your program’s policy regarding 




Authorization to Discuss Health Status with Family, Friends or Advocates Members  
If I am not present or available, I authorize [ENTITY] affiliated treating providers and staff to 
discuss my relevant health information, including my substance use disorder [and mental 
health] treatment, with the family members, friends and/or advocates named below. 
 
 Authorized individuals (please provide full names): 
Name: ______________________________________ Tel # _________________________ 
Name: ______________________________________ Tel # _________________________ 
Name: ______________________________________ Tel # _________________________ 
Name: ______________________________________ Tel # _________________________ 
Name: ______________________________________ Tel # _________________________ 
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Acknowledgement of Rights 
I understand that my substance use disorder treatment records are protected under the federal 
regulations governing Confidentiality and Drug Abuse Patient Records, 42 C.F.R. Part 2, and the 
Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), 45 C.F.R. pts 160 & 164, 
and cannot be disclosed without my written consent unless otherwise provided for by the 
regulations. I understand that if my treating providers disclose my substance use disorder 
treatment records pursuant to this consent, the recipient will be provided a notice of non-
disclosure.  
 
I also understand that I may revoke this consent, orally or in writing by contacting 
[APPROPRIATE ENTITY INFORMATION MANAGEMENT 
OFFICE_____________________________] at [PHONE NUMBER______________] at any time 
except to the extent that action has been taken in reliance on it. We are unable to take back 
any disclosures we have already made with your consent and we are required to retain as 
records of the care we provide to you.  
 
If not already revoked, this consent will expire on __________________ [Example: One 
year/specified date/upon my death.]  
 
Upon request, I can inspect or obtain a copy of the information I am authorizing to be released.  
 
[I understand that I may be denied services if I refuse to consent to a disclosure for purposes of 
my treatment [or payment]. I will not be denied services if I refuse to consent to a disclosure for 
other purposes.]84 
 
If I have any questions about disclosure of my private health information, I can contact 
_________________ at [PHONE NUMBER]. 
 
I understand I can ask for a copy of this authorization and consent form.  
   
 
_________________________________________________________  ____________ 
Signature of Patient or legal representative or guardian   Date and Time 
 
_________________________________________________________   
Authority/Relationship of representative to patient      
(Attach copy of documentation of authority) 
                                                             
84 This provision is not necessary and may be different depending upon the type of provider offering services.  
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How will the Prohibition of Re-disclosure language be communicated to recipients of any Part 2 
Program/SUD records disclosed pursuant to a patient consent?   
PROHIBITION ON RE-DISCLOSURE 
DRAFT FORM C 
 
Each disclosure made with the patient’s written consent must be accompanied by the 
following written statement (42 CFR § 2.32): 
“This information has been disclosed to you from records protected by federal confidentiality 
rules (42 CFR Part 2).  The federal rules prohibit you from making any further disclosure of this 
information in this record that identifies a patient as having or having had a substance use 
disorder either directly, by reference to publicly available information, or through verification of 
such identification by another person unless further disclosure is expressly permitted by the 
written consent of the individual whose information is being disclosed or as otherwise 
permitted by 42 CFR Part 2.  A general authorization for the release of medical or other 
information is NOT sufficient for this purpose (see 2.31). The Federal rules restrict any use of 
the information to investigate  or prosecute with regard to a crime any patient with a substance 
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QUALIFIED SERVICE ORGANIZATION/BUSINESS ASSOCIATE 
AGREEMENT (QSO/BA AGREEMENT)85 
DRAFT FORM D 
 
[Insert entity name] and the [insert program name] hereby enter into an agreement whereby 




  (Nature of services to be provided to the program) 
 
Furthermore, [insert entity name]: 
 
1. acknowledges that in receiving, transmitting, transporting, storing, processing, or 
otherwise dealing with any information received from [insert program name] identifying 
or otherwise relating to the patients in the [insert program name] (‘protected 
information’), it is fully bound by the provision of the federal regulations governing the 
Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R. Part 2; and the 
Health Insurance Portability and Accountability Act (HIPAA), 45 C.F.R. Parts 142, 160, 
162 and 164;  
 
2. agrees to resist any efforts in judicial proceedings to obtain access to the protected 
information except as expressly provided for in the regulations governing the 
Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R. Part 2, as amended;  
 
3. agrees that it will not use or disclose protected health information except as permitted 
or required by the Agreement or by law; 
 
4. agrees that, when the [insert entity name] uses, discloses, or request protected health 
information it will limit the use, disclosure, or request to the minimum necessary; 
 
5. agrees that if the [insert entity name] enters into a contract with any agent, including a 
subcontractor, the agent will agree to comply with 42 C.F.R. Part 2 and HIPAA, and, if 
the [insert entity name] learns of a pattern or practice by the agent that is a material 
breach of the contract with the [insert entity name], to take reasonable steps to cure 
the breach or terminate the contract, if feasible; 
                                                             
85 This Form has been modified from a version published by the Legal Action Center, “QSO/BA Agreement.- Form 
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6. agrees to comply with HIPAA’s security provisions with regard to electronic protected 
health information, and to use appropriate safe guards (can define with more specificity) 
to prevent the unauthorized use or disclosure of the protected information;  
 
7. agrees to report breaches of protected information to the [insert program name];  
 
8. agrees to report to the [insert program name] any use or disclosure of the protected 
information not provided for in this Agreement of which it becomes aware (insert 
negotiated time and manner terms); 
 
9. agrees to ensure that any agent, including a subcontractor, to whom the Center 
provides protected information received from the [insert program name], or creates or 
receives on behalf of the [insert program name], agrees to the same restrictions and 
conditions that apply through this Agreement to the [insert entity name] with respect to 
such information; 
 
10. agrees to provide access to the protected information at the request of the [insert 
program name], or to an individual as directed by the [insert program name], in order to 
meet the requirements of 45 C.F.R. § 164.524 which provides patients with the right to 
access and copy their own protected information (insert negotiated time and manner 
terms); 
 
11. agrees to make any amendments to the protected information as directed or agreed to 
by the [insert program name] pursuant to 45 C.F.R. § 164.524 (insert negotiated time 
and manner terms); 
 
12. agrees to make available its internal practices, books, and records, including policies and 
procedures, relating to the use and disclosure or protected information received from 
the [insert program name], or created or received by the [insert entity name] on behalf 
of the [insert program name], to the [insert program name] or to the Secretary of the 
Department of Health and Human Services for purposes of the Secretary determining 
the [insert program name]’s compliance with HIPAA (insert negotiated time and manner 
terms); 
 
13. agrees to document disclosures of protected information, and information related to 
such disclosures, as would be required for the [insert program name] to respond to a 
request by an individual for an accounting of disclosures in accordance with 45 C.F.R. § 
164.528 (insert negotiated time and manner terms); 
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14. agrees to provide the [insert program name] or an individual in accordance with 
paragraph (9) of this agreement to permit the [insert program name] to respond to a 
request by an individual for an accounting of disclosures in accordance with 45 C.F. R. 45 
C.F.R. § 164.528 (insert negotiated time and manner terms). 
 
Termination 
1. The [insert program name] may terminate this agreement if it determines that the 
[insert entity name] has violated any material term.  
 
2. Upon termination of this Agreement for any reason, the [insert entity name] shall return 
or destroy all protected information received from the [insert program name], or 
created or received by the [insert entity name] on behalf of the [insert program name]. 
This provision shall apply to protected information that is in the possession of 
subcontractors or agents of the [insert entity name]. The [insert entity name] shall 
retain no copies of the protect information.  
 
3. In the event that the [insert entity name] determines that returning or destroying the 
protected information is infeasible, the [insert entity name] shall notify the [insert 
program name] of the conditions that make return or destruction infeasible (insert 
negotiated time and manner terms); 
 
4. Upon notification that the return or destruction of the protected information is 
infeasible, the [insert entity name] shall extend the protections of this Agreement to 
such protected information and limit further uses and disclosures of the information to 
those purposes that make the return or destruction infeasible, as long as, the [insert 
entity name] maintains the information.  
 
 




President      Program Director 
[Entity Name & Address]    [Program Name &
  
   
 
 
 
 
 
 
 
 
 
 
 
  
Notes: 
